BioWorld MedTech

April 12, 2016

Brexit could cost U.K. med-tech firms substantial time, money

PARIS – Leaving the European Union will cost the United Kingdom £100 billion pounds (US$142.5 billion) in gross domestic product and 950,000 jobs by 2020, according to the London-based Confederation of British Industry. Read More

Resilience, and methods to study its causes, exists for Mendelian genetic disorders

Safewire buy consistent with M&A strategy

China's market for orthopedic devices to see explosive growth

Other News to Note

Financings

Keeping you up to date on recent developments in Cardiology

Today's news in brief

BioWorld

BioWorld briefs for April 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 14, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

Illustration of human heart with DNA structure background

Early stage cardio data from Verve bump the stock

BioWorld

Positive early stage data for Verve Therapeutics Inc.’s base editing therapy points to a range of development options, including bringing partner Eli Lilly and...